{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:07:20Z","timestamp":1790078840067,"version":"4.0.1"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>IgA nephropathy (IgAN) is the predominant primary glomerulonephritis worldwide, characterized by the deposition of IgA-containing immune complexes in the glomerular mesangium. Despite advances in supportive care, there is a lack of IgAN-specific therapies capable of halting IgAN progression. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic target, owing to their immunomodulatory, anti-inflammatory, and tissue repair properties. Accumulating evidence suggests that MSCs hold considerable therapeutic potential for the treatment of IgAN. This review summarizes the potential mechanisms underlying the therapeutic effects of MSCs in IgAN, with a particular focus on their roles in the gut, liver, and kidney, and discusses current challenges and future directions for MSCs-based therapies.<\/jats:p>","DOI":"10.3389\/fphar.2026.1885100","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:21:34Z","timestamp":1790076094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal stem cells: a potential therapeutic strategy for IgA nephropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Jia","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[{"name":"Jilin Tuohua Biotechnology Co., Ltd.","place":["Siping, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[{"name":"Jilin Tuohua Biotechnology Co., Ltd.","place":["Siping, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Jilin Tuohua Biotechnology Co., Ltd.","place":["Siping, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, People\u2019s Hospital of Jilin City","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/pharmaceutics14020381","article-title":"Mesenchymal stem\/stromal cells and their paracrine activity-immunomodulation mechanisms and how to influence the therapeutic potential","volume":"14","author":"Alvites","year":"2022","journal-title":"Pharmaceutics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.kint.2022.09.017","article-title":"Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy","volume":"103","author":"Barratt","year":"2023","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4252\/wjsc.v6.i5.644","article-title":"Potential advantages of acute kidney injury management by mesenchymal stem cells","volume":"6","author":"Bianchi","year":"2014","journal-title":"World J. Stem Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.1840090518","article-title":"The liver and IgA: immunological, cell biological and clinical implications","volume":"9","author":"Brown","year":"1989","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"sfae237","DOI":"10.1093\/ckj\/sfae237","article-title":"Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy","volume":"17","author":"Caravaca-Font\u00e1n","year":"2024","journal-title":"Clin. Kidney J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1886","DOI":"10.1371\/journal.pone.0001886","article-title":"Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing","volume":"3","author":"Chen","year":"2008","journal-title":"Plos One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00281-018-0708-7","article-title":"IgA nephropathy: clearance kinetics of IgA-containing immune complexes","volume":"40","author":"Chen","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"Cheung","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/biomedicines12081849","article-title":"Mesenchymal stromal cell-derived extracellular vesicles for reversing hepatic fibrosis in 3D liver spheroids","volume":"12","author":"Chiabotto","year":"2024","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S633","DOI":"10.1016\/j.ekir.2024.11.1128","article-title":"WCN25-482 mesenchymal stem cell might be a rescue therapy in severe IgA nephropathy with CKD","volume":"10","author":"Cho","year":"2025","journal-title":"Kidney Int. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/j.1572-0241.2002.06025.x","article-title":"Celiac disease and HLA DQ in patients with IgA nephropathy","volume":"97","author":"Collin","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103327","DOI":"10.1016\/j.autrev.2023.103327","article-title":"Glomerulonephritis and inflammatory bowel disease: a tale of gut-kidney axis dysfunction","volume":"22","author":"Doumas","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","article-title":"Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy","volume":"77","author":"Fan","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/s0140-6736(17)30550-0","article-title":"Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial","volume":"389","author":"Fellstr\u00f6m","year":"2017","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2295431","DOI":"10.1080\/0886022x.2023.2295431","article-title":"Identification of common and specific fibrosis-related genes in three common chronic kidney diseases","volume":"46","author":"Fu","year":"2024","journal-title":"Ren. Fail"},{"key":"B19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1415026","DOI":"10.3389\/fimmu.2024.1415026","article-title":"Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"151564","DOI":"10.1016\/j.semnephrol.2025.151564","article-title":"IgA nephropathy: epidemiology and disease risk across the world","volume":"44","author":"Ghaddar","year":"2024","journal-title":"Seminars Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","article-title":"In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis","volume":"38","author":"Gholamrezanezhad","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-022-02811-5","article-title":"The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer","volume":"13","author":"Guo","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/08923973.2015.1080265","article-title":"Anti-inflammatory effects of triptolide on IgA nephropathy in rats","volume":"37","author":"He","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1854005","DOI":"10.3389\/fimmu.2026.1854005","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes are associated with changes in renal injury markers, gut microbiota composition, and inflammatory signaling in IgA nephropathy","volume":"17","author":"He","year":"2026","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/rme.14.73","article-title":"The translation of cell-based therapies: clinical landscape and manufacturing challenges","volume":"10","author":"Heathman","year":"2015","journal-title":"Regen. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12967-019-02167-0","article-title":"The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation","volume":"17","author":"Hu","year":"2019","journal-title":"J. Transl. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7150\/ijbs.39725","article-title":"Mesenchymal stromal cells promote liver regeneration through regulation of immune cells","volume":"16","author":"Hu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2174\/1566524023666230720112215","article-title":"Follicular helper T cells in Peyer's patches and Galactose- deficient Iga1 contribute to Iga nephropathy","volume":"24","author":"Huang","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1677021","DOI":"10.3389\/fmed.2025.1677021","article-title":"Harnessing mesenchymal stromal cells for liver disease therapy: from mechanistic discoveries to clinical breakthroughs","volume":"12","author":"Huang","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3727\/096368912X639008","article-title":"Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy","volume":"21","author":"Hyun","year":"2012","journal-title":"Cell Transpl."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/sctm.19-0113","article-title":"Rat mesenchymal stromal cell sheets suppress renal fibrosis via microvascular protection","volume":"8","author":"Imafuku","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1046\/j.1523-1755.1999.00750.x","article-title":"Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder","volume":"56","author":"Imasawa","year":"1999","journal-title":"Kidney Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"963689720965467","DOI":"10.1177\/0963689720965467","article-title":"Protective effects of human nonrenal and renal stromal cells and their conditioned media in a rat model of chronic kidney disease","volume":"29","author":"Imberti","year":"2020","journal-title":"Cell Transpl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1681\/ASN.2018101017","article-title":"Mortality in IgA nephropathy: a nationwide population-based cohort study","volume":"30","author":"Jarrick","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13287-024-03878-y","article-title":"Umbilical cord mesenchymal stem cells in ulcerative colitis treatment: efficacy and possible mechanisms","volume":"15","author":"Jiang","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.akdh.2023.11.002","article-title":"Liver disease-associated glomerulopathies","volume":"31","author":"Kanduri","year":"2024","journal-title":"Adv. Kidney Dis. Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.3390\/jcm10194501","article-title":"Pathogenesis of IgA nephropathy: current understanding and implications for development of disease-specific treatment","volume":"10","author":"Knoppova","year":"2021","journal-title":"J. Clin. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/s0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells and clinical experience","volume":"262","author":"Le Blanc","year":"2007","journal-title":"J. Intern Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"B44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/xen.12000","article-title":"Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation","volume":"19","author":"Li","year":"2012","journal-title":"Xenotransplantation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/scrt314","article-title":"Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor","volume":"4","author":"Li","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12882-025-04029-y","article-title":"Immunomodulatory effects of mesenchymal stem cell therapy in chronic kidney disease: a literature review","volume":"26","author":"Li","year":"2025","journal-title":"BMC Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3727\/096368910X557245","article-title":"Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis","volume":"20","author":"Liang","year":"2011","journal-title":"Cell Transpl."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1159\/000430151","article-title":"Proliferation and cytokine production of human mesangial cells stimulated by secretory IgA isolated from patients with IgA nephropathy","volume":"36","author":"Liang","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2147\/ijn.s402179","article-title":"HucMSC-Exo promote mucosal healing in experimental colitis by accelerating intestinal stem cells and epithelium regeneration via wnt signaling pathway","volume":"18","author":"Liang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"B50","doi-asserted-by":"publisher","first-page":"960208","DOI":"10.3389\/fcimb.2022.960208","article-title":"Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2303396","DOI":"10.1080\/0886022x.2024.2303396","article-title":"Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1\/FOXO1 pathway","volume":"46","author":"Liu","year":"2024","journal-title":"Ren. Fail"},{"key":"B52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13287-026-05012-6","article-title":"The role of mesenchymal stem cells in IgA nephropathy: current evidence and future directions","volume":"17","author":"Liu","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.18502\/ijaai.v20i6.8022","article-title":"Immunomodulatory effect of human umbilical cord blood-derived mesenchymal stem cells on activated T-lymphocyte","volume":"20","author":"Lotfinejad","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2022.5368","article-title":"Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy the TESTING randomized clinical trial","volume":"327","author":"Lv","year":"2022","journal-title":"Jama-Journal Am. Med. Assoc."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1511525","DOI":"10.3389\/fphar.2024.1511525","article-title":"Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis","volume":"15","author":"Lv","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1056\/nejmoa2514415","article-title":"Telitacicept for IgA nephropathy - interim analysis of a phase 3 trial","volume":"394","author":"Lv","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cdd.2013.158","article-title":"Immunobiology of mesenchymal stem cells","volume":"21","author":"Ma","year":"2014","journal-title":"Cell Death Differ."},{"key":"B58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5114\/wo.2017.68616","article-title":"Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer","volume":"21","author":"Mao","year":"2017","journal-title":"Contemp. Oncol. Pozn."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e108723","DOI":"10.1371\/journal.pone.0108723","article-title":"Hemolytic Streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells","volume":"9","author":"Meng","year":"","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"","journal-title":"Nat. Rev. Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/mog.0000000000000789","article-title":"Role of gut-kidney axis in renal diseases and IgA nephropathy","volume":"37","author":"Monteiro","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/cells13171460","article-title":"How stem and progenitor cells can affect renal diseases","volume":"13","author":"Montenegro","year":"2024","journal-title":"Cells"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1089\/scd.2010.0140","article-title":"Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide","volume":"19","author":"Mosna","year":"2010","journal-title":"Stem Cells Dev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"637725","DOI":"10.3389\/fcell.2021.637725","article-title":"Immunomodulatory properties of mesenchymal stromal cells: an update","volume":"9","author":"M\u00fcller","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11255-006-0061-y","article-title":"Immunoglobulin A nephropathy complicating ulcerative colitis","volume":"38","author":"Onime","year":"2006","journal-title":"Int. Urol. Nephrol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.3390\/ijms20246199","article-title":"The role of IgA in the pathogenesis of IgA nephropathy","volume":"20","author":"Per\u0161e","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"key":"B68","doi-asserted-by":"publisher","first-page":"aaf4822","DOI":"10.1126\/science.aaf4822","article-title":"IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches","volume":"352","author":"Reboldi","year":"2016","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.160.1.125","article-title":"Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice","volume":"160","author":"Rifai","year":"1984","journal-title":"J. Exp. Med."},{"key":"B70","first-page":"4855","article-title":"Case report: effect of umbilical cord mesenchymal stem cells on immunoglobulin A nephropathy after acute renal failure","volume":"14","author":"Riordan","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"B72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"Samir","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.3390\/jcm10132925","article-title":"Biodistribution of mesenchymal stromal cells after administration in animal models and humans: a systematic review","volume":"10","author":"Sanchez-Diaz","year":"2021","journal-title":"J. Clin. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.34067\/kid.0002382022","article-title":"The gut and kidney crosstalk in immunoglobulin A nephropathy","volume":"3","author":"Sanchez-Russo","year":"2022","journal-title":"Kidney360"},{"key":"B75","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1073\/pnas.1820892116","article-title":"Small-molecule factor B inhibitor for the treatment of complement-mediated diseases","volume":"116","author":"Schubart","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e70170","DOI":"10.1371\/journal.pone.0070170","article-title":"Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration","volume":"8","author":"S\u00e9mont","year":"2013","journal-title":"Plos One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12967-024-05282-9","article-title":"Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation","volume":"22","author":"Sitbon","year":"2024","journal-title":"J. Transl. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical trials with mesenchymal stem cells: an update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transpl."},{"key":"B79","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"105128","DOI":"10.1016\/j.ebiom.2024.105128","article-title":"hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study","volume":"103","author":"Sun","year":"2024","journal-title":"EBioMedicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00467-002-0943-x","article-title":"An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications","volume":"17","author":"Takemura","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"883168","DOI":"10.3389\/fmed.2022.883168","article-title":"Protocol for a phase 1, open-label, multiple-center, dose-escalation study to evaluate the safety and tolerability of ADR-001 in the treatment of immunoglobulin A nephropathy","volume":"9","author":"Tanaka","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.34067\/kid.0000000000000563","article-title":"Safety and tolerability of adipose-derived mesenchymal stem cell (ADR-001) therapy for IgA nephropathy","volume":"5","author":"Tanaka","year":"2024","journal-title":"Kidney360"},{"key":"B84","doi-asserted-by":"publisher","first-page":"944027","DOI":"10.3389\/fmed.2022.944027","article-title":"Gut dysbiosis and intestinal barrier dysfunction promotes IgA nephropathy by increasing the production of Gd-IgA1","volume":"9","author":"Tang","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12882-016-0344-1","article-title":"The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease","volume":"17","author":"Terasaka","year":"2016","journal-title":"BMC Nephrol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13287-016-0416-y","article-title":"Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1\/2-Fas\/FasL-caspase3 pathway regulation","volume":"7","author":"Tian","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrneph.2009.229","article-title":"Mesenchymal stem cells: a new therapeutic tool for AKI","volume":"6","author":"T\u00f6gel","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ki.1997.361","article-title":"Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG","volume":"52","author":"Tomana","year":"1997","journal-title":"Kidney Int."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s40620-025-02213-9","article-title":"Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis","volume":"38","author":"Umezawa","year":"2025","journal-title":"J. Nephrol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/76261","article-title":"Fc\u03b1RI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity","volume":"6","author":"van Egmond","year":"2000","journal-title":"Nat. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","article-title":"Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials","volume":"23","author":"Wang","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000524111","article-title":"Th17 cells participate in Thy1.1 Glomerulonephritis which is ameliorated by tacrolimus","volume":"53","author":"Watanabe","year":"2022","journal-title":"Am. J. Nephrol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"eaav8521","DOI":"10.1126\/scitranslmed.aav8521","article-title":"Advances in therapeutic applications of extracellular vesicles","volume":"11","author":"Wiklander","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"B96","doi-asserted-by":"publisher","first-page":"985030","DOI":"10.3389\/fphar.2022.985030","article-title":"Emerging role of extracellular vesicles in kidney diseases","volume":"13","author":"Xiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/modpathol.2010.110","article-title":"Podocyte number predicts progression of proteinuria in IgA nephropathy","volume":"23","author":"Xu","year":"2010","journal-title":"Mod. Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0159426","DOI":"10.1371\/journal.pone.0159426","article-title":"Critical role of kupffer cell CD89 expression in experimental IgA nephropathy","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13287-023-03263-1","article-title":"Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3 + Treg cells and gut microbiota","volume":"14","author":"Yan","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061599","article-title":"Effects of periostracum cicadae on cytokines and apoptosis regulatory proteins in an IgA Nephropathy Rat model","volume":"19","author":"Yang","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease","volume":"14","author":"Yang","year":"","journal-title":"Nat. Rev. Nephrol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"103560","DOI":"10.4252\/wjsc.v17.i3.103560","article-title":"Immunomodulatory effects and clinical application of exosomes derived from mesenchymal stem cells","volume":"17","author":"Yi","year":"2025","journal-title":"World J. Stem Cells"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1889646","DOI":"10.3389\/fimmu.2026.1889646","article-title":"Gut microbiota dysbiosis and immune responses: insights from IgA nephropathy and inflammatory bowel disease","volume":"17","author":"Yi","year":"2026","journal-title":"Front. Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12026-015-8660-2","article-title":"Mesenchymal stromal cell-dependent reprogramming of Kupffer cells is mediated by TNF-\u03b1 and PGE2 and is crucial for liver transplant tolerance","volume":"62","author":"You","year":"2015","journal-title":"Immunol. Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13287-025-04841-1","article-title":"Umbilical cord mesenchymal stromal cells in sarcopenia: benefits and strategies for enhancing efficacy","volume":"17","author":"Yu","year":"2025","journal-title":"Stem Cell Res. and Ther."},{"key":"B106","first-page":"609","article-title":"Repair effects of umbilical cord mesenchymal stem cells on podocyte damage of iga nephropathy","volume":"29","author":"Zhang","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1128393","DOI":"10.3389\/fmed.2023.1128393","article-title":"Molecular insight in intrarenal inflammation affecting four main types of cells in nephrons in IgA nephropathy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s11596-025-00068-6","article-title":"Crosstalk between Th17 cells and renal tubular epithelial cells promotes fibrotic progression in IgA nephropathy","volume":"45","author":"Zhou","year":"2025","journal-title":"Curr. Med. Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e73425","DOI":"10.1371\/journal.pone.0073425","article-title":"Synergistic effect of mesangial cell-induced CXCL1 and TGF-\u03b21 in promoting podocyte loss in IgA nephropathy","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"key":"B110","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/scd.2025.0038","article-title":"Mesenchymal stem cells attenuate podocyte injury in diabetic nephropathy through the promotion of type 2 macrophage polarization","volume":"34","author":"Zhu","year":"2025","journal-title":"Stem Cells Dev."},{"key":"B111","first-page":"4289","article-title":"Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats","volume":"8","author":"Zou","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1885100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:21:36Z","timestamp":1790076096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1885100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":112,"alternative-id":["10.3389\/fphar.2026.1885100"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1885100","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1885100"}}